Skip to main content

Mar Tintore Subirana

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

Mar Tintore Subirana

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Director
Multiple Sclerosis Centre of Catalonia

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 369 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until April 2026 my work has received 26,854 citations.

Projects

Validación de marcadores biológicos asociados con la conversión a esclerosis múltiple en pacientes que presentan síndromes clínicos aislados

IP: Manuel Comabella Lopez
Collaborators: Mar Tintore Subirana
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI09/00788
Duration: 01/01/2010 - 30/06/2013

Estudio de marcadores biológicos pronóstico en pacientes con síndromes clínicos aislados sugestivos de esclorosis múltiple

IP: Mar Tintore Subirana
Collaborators: Jordi Rio Izquierdo, Rosalia Horno Ocaña, Georgina Arrambide García, Alex Rovira Cañellas, Joaquin Castillo Justribo, Mireia Castillo Juarez
Funding agency: Instituto de Salud Carlos III
Funding: 59229.5
Reference: PI080788
Duration: 01/01/2009 - 30/06/2012

Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clinica y radiológica de dosis equivalentes de metilprednisolona administradas por vía oral o vía intravenosa en pacientes en brote de esclerosis múltiple.

IP: Mar Tintore Subirana
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 0.0001
Reference: CORTEM2007-000888-15
Duration: 01/01/2007 - 31/12/2008

Espectroscopia por RM de protón e imagen de transferencia de magnetización en el estudio de primeros episodios sugestivos de Esclerosis Múltiple.

IP: -
Collaborators: Alex Rovira Cañellas, Mar Tintore Subirana
Funding agency: Instituto de Salud Carlos III
Funding: 40940
Reference: PI020971
Duration: 06/11/2002 - 31/12/2005

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Lluc Molins Ciutat

Lluc Molins Ciutat

Gestió i Administració
Commercial and Academic Clinical Research
Read more
Idoia Bolinaga Ayala

Idoia Bolinaga Ayala

Predoctoral researcher
Protein kinases in cancer research
Read more
Raquel Andreu Vilarroig

Raquel Andreu Vilarroig

Research technician
Childhood Cancer and Blood Disorders
Read more
Daniel León González

Daniel León González

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.